High-end brands have more to worry about than just tariffs and the prospect of reduced consumer spending.

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

- 08:15 (EU) ECB Interest Rate Decision: Expected to cut Key Rates by 25bps; Expected to cut Deposit Rate by 25bps to 2.25%; ...

A chartmaster who was wary of US stocks in January explained why the downturn isn't over yet, and where investors can hide ...

Sensex jumped 1007.23 pts or 1.31 per cent to 78,051.52 as at 12.33 pm, and Nifty 50 soared 267.05 pts or 1.14% to 23,704.25.

The benchmark KSE-100 index declined over 1,300 points to close at 114,853. Market activity was overshadowed by broad-based pressure, with heavyweight stocks such as UBL, Fauji Fertiliser Company, ...

Falling crude oil prices to reduce the cost of APIs like Paracetamol, Amoxicillin and Cefixime, which already dropped 10–20pc ...

Premium InsightsThe Hepatitis C drug market is entering a transformative phase as global health organizations, pharmaceutical ...

London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled ...

London stocks had extended losses by midday on Wednesday as Trump’s sweeping tariffs came into force, including a swingeing ...